These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [Physicochemical properties of the diabetogenic factor and its complex with heparin]. Kudriashov BA; Ammosova IaM; Liapina LA; Ul'ianov AM Farmakol Toksikol; 1987; 50(3):49-52. PubMed ID: 3609278 [TBL] [Abstract][Full Text] [Related]
49. Experience with the intramuscular administration of heparin preparations; a comparison between aqueous and retard heparin. FANTL P; EBBELS L Australas Ann Med; 1952 Nov; 1(2):135-9. PubMed ID: 13008902 [No Abstract] [Full Text] [Related]
50. Intramuscular aqueous heparin. GUBBAY ER; PASH E Can Med Assoc J; 1953 Aug; 69(2):105-7. PubMed ID: 13067044 [No Abstract] [Full Text] [Related]
51. Intramuscular administration of heparin. BAUER G; BOSTROM H Acta Med Scand; 1949 Jan; 136(3):188-98. PubMed ID: 15404964 [No Abstract] [Full Text] [Related]
55. [Recovery of the anticoagulation system function in patients with insulin-dependent diabetes by neutralization of the activity of diabetogenic factor]. Kudriashov BA; Balabolkin MI; Ul'ianov AM; Liapina LA; Levitskaia ZI Vopr Med Khim; 1990; 36(3):79-81. PubMed ID: 2382439 [TBL] [Abstract][Full Text] [Related]
56. [Complex-formation of heparin with the plasma diabetogenic factor]. Kudriashov BA; Liapina LA Vopr Med Khim; 1986; 32(2):64-5. PubMed ID: 3705518 [TBL] [Abstract][Full Text] [Related]
57. [C-peptide, diabetogenic factor and the blood anticoagulating system in patients with the insulin-dependent type of diabetes mellitus before and after heparin therapy]. Balabolkin MI; Kudriashov BA; Levitskaia ZI; Liapina LA; Ul'ianov AM Probl Endokrinol (Mosk); 1990; 36(1):25-8. PubMed ID: 2330356 [TBL] [Abstract][Full Text] [Related]